transparency

The Trump administration is considering a proposal to require all published research that has received federal funding to be made immediately available to the public at no cost.
A new paper in the Journal of Public Health Policy raises the concern that despite ever-tightening disclaimers of conflicts of interest (COI) in scientific research, unwarranted influence may be hidden in funding.
Most people agree that drug prices in America are way too high. The disagreement centers on the cause and what to do about it, if anything.
Piggybacking on du jour terminology like “social determinants of health” don’t make privacy erosions by insurance carriers more legitimate or less fraught with ethical conundrums.
Two bills were passed by the House of Representatives this week whose aims overlap to a degree: